Abajar, Fe A.

HRN: 24-33-19  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/08/2024
02/14/2024
IV
2.25g
Q8
CAP-MR
Rejected 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines